The FDA has approved Otsuka Pharmaceutical’s SIMTRIYO (centanafadine) for the treatment of attention...

The Food and Drug Administration’s (FDA) proposed plan to cap the nicotine content of cigarettes at ...

A novel blood-based test that can help differentiate between schizophrenia and bipolar disorder may ...

The Food and Drug Administration (FDA) this week requested that manufacturers of glucagon-like pepti...

January The FDA approves the esketamine nasal spray Spravato as a monotherapy for adults with treatm...

Only 19% of Americans are familiar with kratom, a plant touted as a “natural opiate” and sometimes r...